Ronald Werner

Ronald Werner is an experienced professional in the pharmaceutical sales sector, currently serving as the National Sales Manager for Haemophilia at Sobi - Swedish Orphan Biovitrum AB (publ) since January 2020. Prior to this role, Ronald held various positions, including Key-Account-Manager at AstraZeneca from August 2016 to January 2020, and Therapy Area Specialist for Lung Cancer. Ronald's earlier experience includes roles at Celgene, UCB, Die Grünenthal Gruppe, and AstraZeneca, focusing on specialty sales across various therapeutic areas such as rheumatology, neurology, and analgesics. Ronald began a career in pharmaceutical sales as a Pharmaberater for gastroenterology at Eisai EMEA from March 2008 to June 2009. Ronald holds a Diplom in Molecular Biology from Universität Rostock, obtained between 2000 and 2007.